Skip to main content
Quest Diagnostics

Genetic Findings in a Cohort of Over 600 Patients Tested With a Multi-Gene Hereditary Neuropathy Panel

NSGC 2024 43rd Annual Conference

National Society of Genetic Counselors

New Orleans, LA, Sep 17-21, 2024

Poster presentation: Genetic Findings in a Cohort of Over 600 Patients Tested With a Multi-Gene Hereditary Neuropathy Panel

Authors: Sesler CL, Wylezinski LS, Shaginurova GI, Grigorenko EV, Cockerill FR, III, Racke MK, Spurlock CF, III

Specialty: Genetics, Neurology

Disclaimer: One or more of the authors of this abstract were employed at the time by BluePrint Genetics, a subsidiary of Quest Diagnostics.

Related content

Audio Podcast
Patient-minded Neurology

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.